Covid-19: Booster doses to be offered to 30 million people in UKBMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n2261 (Published 14 September 2021) Cite this as: BMJ 2021;374:n2261
- Jacqui Wise
Booster doses of a covid-19 vaccine are to be offered to the highest risk groups in the UK as a result of new advice from the Joint Committee on Vaccination and Immunisation.
A booster dose will be offered to all people who were vaccinated during phase 1 of the vaccine programme, no earlier than six months after they received their second dose. The JCVI advises a preference for the Pfizer-BioNTech vaccine regardless of which vaccine someone had for their primary doses. This follows data from the Cov-boost trial that indicated that this vaccine is well tolerated as a third dose and provides a strong booster response.
The JCVI said that it was taking a “precautionary position” and that on balance it was preferable to maintain a …